Voters and markets are rejecting both utopian promises and catastrophic resignation, instead embracing pragmatic assessment of deliverable outcomes. Democratic midterm victories centered on tangible healthcare affordability, not ideology; pharmaceutical executives openly skeptical of Silicon Valley's AI drug-discovery hype; investment recalibration away from speculative AI valuations toward yields and proven returns. This reflects Optimism in Making: the offer itself (verifiable progress, realistic delivery) is the counter-cynicism.